About Zinc finger protein 436
Zinc finger protein 436 (ZNF436) is a protein
from Homo sapiens identified by UniProt accession
Q9C0F3, 470 residues long.
MolForge cross-references it against 0 known binders and
32 disease associations.
Target properties
| Protein name | Zinc finger protein 436 |
| UniProt accession | Q9C0F3 |
| Gene | ZNF436 |
| Organism | Homo sapiens |
| Length | 470 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (32)
Diseases linked to this target (Open Targets).
- glomerular filtration rate · score 0.41
- neurodegenerative disease · score 0.39
- creatinine measurement · score 0.37
- BMI-adjusted waist circumference · score 0.29
- sex hormone-binding globulin measurement · score 0.29
- BMI-adjusted waist-hip ratio · score 0.28
- waist-hip ratio · score 0.19
- risk-taking behaviour · score 0.16
- cystatin C measurement · score 0.16
- eosinophil percentage of leukocytes · score 0.13
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9C0F3-F1 | alphafold | PREDICTED | 77.50 | — |
Amino-acid sequence (470 residues)
MAATLLMAGS QAPVTFEDMA MYLTREEWRP LDAAQRDLYR DVMQENYGNV VSLDFEIRSE NEVNPKQEIS EDVQFGTTSE RPAENAEENP ESEEGFESGD RSERQWGDLT AEEWVSYPLQ PVTDLLVHKE VHTGIRYHIC SHCGKAFSQI SDLNRHQKTH TGDRPYKCYE CGKGFSRSSH LIQHQRTHTG ERPYDCNECG KSFGRSSHLI QHQTIHTGEK PHKCNECGKS FCRLSHLIQH QRTHSGEKPY ECEECGKSFS RSSHLAQHQR THTGEKPYEC NECGRGFSER SDLIKHYRVH TGERPYKCDE CGKNFSQNSD LVRHRRAHTG EKPYHCNECG ENFSRISHLV QHQRTHTGEK PYECNACGKS FSRSSHLITH QKIHTGEKPY ECNECWRSFG ERSDLIKHQR THTGEKPYEC VQCGKGFTQS SNLITHQRVH TGEKPYECTE CEKSFSRSSA LIKHKRVHTD
Explore Zinc finger protein 436 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets